OTC · Medical - Pharmaceuticals

Nunzia Pharmaceutical Company (NUNZ) Stock

$0.00 OTC: NUNZ Healthcare

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders.

Valuation

MetricValue
Price$0.00
Market Cap$43451
P/E Ratio0.00
P/B Ratio-0.32
P/S Ratio0.00
EPS (TTM)$-0.26
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.03
Current Ratio0.00

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$-78.0M
Net Profit$0$0$0$-101.0M$-78.0M
EPS$0.00$0.00$0.00$-0.35$-0.26
Op Margin—————

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$0$0$0$-9.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$-9.0M$0
Free Cash Flow$0$0$0$-9.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.00
FCF Yield-199.71%
Quick Ratio0.00
Interest Coverage-41923.15
Return 1Y-96.67%
Return 3Y-96.67%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKANAkanda Corp. $1.76 -1.12% -0.01 $56964 0.00%
CSUICannabis Suisse Corp. $0.01 -4.49% 5.67 $600788 0.00%
IMCCIM Cannabis Corp. $1.58 -8.14% -1.13 $954195 0.00%
RDHLRedHill Biopharma Ltd. $0.60 +0.82% -0.30 $1.89M 0.00%
STSNStemsation International, Inc. $0.02 +2.84% -24.55 $1.50M 0.00%

About Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

Nunzia Pharmaceutical Company (NUNZ) stock trades at $0.00 with a market capitalization of $43451. The stock is valued at a negative price-to-book of -0.32, reflecting negative shareholders' equity, price-to-sales of 0.00.

Official website: www.nunziapharma.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.